The JCMS Dermatology Podcast with Dr Kirk Barber

"A lot of us have had patients with PRP who went on a biologic and they cleared quite rapidly and were very happy afterwards." Dr Patrick Fleming joins Kirk Barber, JCMS editor-in-chief, to discuss his article in the Jan/Feb 2020 issue of the journal, titled: “Use of Biologics in Pityriasis Rubra Pilaris Refractory to First-Line Systemic Therapy: A Systematic Review.“ Dr Patrick Fleming talks abou...

Dr Catherine McCuaig joins Dr Kirk Barber, Editor-in-Chief of the Journal of Cutaneous Medicine and Surgery, for a fascinating discussion about her article in the July/August edition of the Journal. It is a retrospective single-centre study of children with IBD under anti-TNF treatment between 2013 and 2016. Forty patients with CSE related to anti-TNF were referred to Dr McCuaig's pediatric dermat...

Dr Regine Mydlarski joins Kirk Barber, Editor in Chief of the Journal of Cutaneous Medicine, for a fascinating snapshot of what Canadian Dermatology looks like today and what changes need to be made to meet the evolving needs of patients across Canada. As Chair of the Dermatology Working Group at the Royal College of Physicians and Surgeons of Canada, Dr Mydlarski led a comprehensive and objective...

"They want to live without the fear of discrimination due to the appearance of their skin. In the context of June 2020 and Black Lives Matter and racism, this seems to be a very timely thing the patients have brought up." Dr Harvey Lui is JCMS Editor-in-Chief Dr Kirk Barber's guest on this edition of JCMS Author Interviews. They discuss Dr Lui's article, "Developing a Patient Charter for People Li...

Dr Steven Feldman is JCMS Editor-in-Chief Dr Kirk Barber's guest on this latest edition of JCMS Author Interviews. The two have an in-depth conversation about the importance of empathy, or the appearance of empathy by doctors, as a means of getting patients to do a better job of treating themselves or their families. This conversation is based on the Article “Assessing the Effect of Clinical Trial...

Dr. Kirk Barber interviews Dr. Aaron Drucker, one of the authors of "Canadian burden of skin disease from 1990 to 2017: Results from the Global Burden of Disease 2017 study," in the March-April edition of the Journal of Cutaneous Medicine and Surgery. Kirk and Aaron discuss some of the most important discoveries in the data found in the study and why it is a treasure trove for research and for put...

Dr. Catherine Besner-Morin talks with JCMS editor-in-chief Dr. Kirk Barber about the article on treating itch that she co-authored in the September-October 2019 issue of the Journal of Cutaneous Medicine and Surgery. Itch treatment is a major challenge in the dermatologist’s practice. We encounter patients suffering from pruritus on a regular basis, and often lack diverse treatment options to adeq...

Dr. Michele Ramien talks with JCMS editor-in-chief Dr. Kirk Barber about the article she co-authored in the Nov-Dec 2019 issue of the Journal of Cutaneous Medicine and Surgery. In their conversation, Michele describes to Kirk the potential efficacy of cyclosporine A in the treatment of Mycoplasma pneumoniae-induced rash and mucositis, also known as MIRM. MIRM is a relatively newly recognized clini...

Dr. Robert Gniadecki speaks with JCMS Editor-in-chief, Dr. Kirk Barber, about the article Gniadecki co-authored in the Sept/Oct 2019 edition of the Journal of Cutaneous Medicine and Surgery. They discuss two progressive primary cutaneous T-cell lymphomas for which there are no curative treatments, Mycosis fungoides and Sézary syndrome. Dr Gniadecki explains why Immunotherapy seems to be a promisin...

Dr. Jan Dutz speaks with JCMS Editor-in-chief Dr Kirk Barber about the article Dutz co-authored in the Nov/Dec 2019 edition of the Journal of Cutaneous Medicine and Surgery. The article focuses on how East Asians exposed to the urate-lowering drug allopurinol have a predilection for severe cutaneous drug reactions such as drug-induced hypersensitivity syndrome or drug reaction with eosinophilia an...

Dr Melinda Gooderham speaks with JCMS Editor-in-chief Dr Kirk Barber about her literature review in the May/June 2019 edition of JCMS. Dr Gooderham and her co-author Nicole Relke looked at vitiligo pathophysiology, reviewed current therapy and discussed the potential value of JAK inhibitors. Their literature review shows JAK inhibitors in patients with vitiligo have a favorable safety profile and...

Dr Mark Kirchhof speaks with JCMS Editor-in-chief Dr. Kirk Barber about his innovative proposal for the treatment of Hidradenitis Suppurativa (HS). Clinicians typically follow a linear approach to the treatment of HS in which one modality is attempted before moving on to the next. Dr Kirchhoff's paper challenges this sequential approach to treating Hidradenitis Suppurativa and instead proposes a m...

JCMS editor-in-chief Dr Kirk Barber speaks with Dr Patrick Fleming, one of the authors of a new manuscript that offers an extensive comparison of international guidelines on a wide range of therapies for the treatment of moderate-to-severe plaque psoriasis from phototherapy, to biologics to molecule-based strategies. Dr Fleming and his co-authors looked at the guidelines in Canada, the United King...

Despite the lack of evidence to validate the effectiveness and safety of marijuana, it is approved to treat a variety of dermatologic conditions in the United States. Health Canada has listed psoriasis, dermatitis, and pruritus as potential therapeutic uses for cannabis. Furthermore, medical cannabis dispensaries have been making unsubstantiated claims about medical cannabis. It is important for d...

One of the leading authorities on psoriasis in the world, Dr Kim Papp speaks with JCMS Editor-in-Chief Dr Kirk Barber about his outstanding report on vaccination guidelines for patients with immune-mediated disorders on immunosuppressive therapies. Dr Papp was the lead author on this multi-disciplinary effort. According to Dr Barber, the paper provides clinicians with a clear path to develop their...

JCMS Editor-in-chief Dr Kirk Barber speaks with Dr Christian Murray, a co-author of a vast systematic review of the literature for patient indications for micrographic surgery. Dr Murray is an accredited Moh's surgeon, associate professor of medicine at Women's College at the University of Toronto and director of the ACMS-accredited Mohs Surgery Fellowship at the University of Toronto. This interv...

Editor-in-Chief Dr Kirk Barber speaks with Dr Michele Ramien, a clinical associate professor of pediatric dermatology at University of Calgary and co-author of a study on the development of an eczema action plan (EAP) as an individualized tool to help caregivers and patients self-manage eczema. While novel illustrated EAPs have been developed and validated and this study supports those findings as...

Editor-in-chief of JCMS, Dr Kirk Barber speaks with Dr Afsaneh Alavi, a co-author of the study that aimed to systematically review the published evidence on the treatment of ulcerated hemangiomas, focusing on wound healing as the outcome of interest. Dr Alavi is a clinical dermatologist and Assistant Professor in the Faculty of Medicine (Division of Dermatology) at the University of Toronto.

Over the past decade, new technologies, devices, and methods have been developed to assist in the diagnosis of cutaneous melanocytic lesions. A study published in the November December 2018 issue of JCMS evaluates the performance of an augmented intelligence system in the assessment of atypical pigmented lesions. On this episode, Editor-In-Chief Dr Kirk Barber speaks with two of the paper's co-aut...

In this special episode, Dr. Kirk Barber speaks with the lead co-authors of a supplement which was published in the November 2018 edition of the journal titled, “The Approach To The Assessment And Management Of Adult Patients With Atopic Dermatitis: A Consensus Document.” The supplement and this episode are sponsored by Sanofi Genzyme but they had no input into the content of either. The consensus...

JCMS Editor-in-chief Dr Kirk Barber speaks with Dr Neil Shear about research he conducted along with his co-authors to determine the efficacy, adverse effects, and safety profile of methotrexate therapy in patients with atopic dermatitis. Dr Neil Shear is the Head of Dermatology at Sunnybrook & Women's College Health Sciences Centre. He is also a professor in Clinical Pharmacology & Toxico...

Editor-in-Chief, Dr Kirk Barber speaks with Dr Neil Kitson, a clinical dermatologist and Associate Professor in the Department of Dermatology and Science at the University of British Columbia about his and his co-authors' research into the use of cell phone text messages with clinical photos in medical practice, whether in rural or urban settings. They discuss the results of their research survey...

Dr Kirk Barber speaks with Dr Sheetal Sapra, a dermatologist and co-founder of the Institute of Cosmetic and Laser Surgery in Oakville Ontario, about the study he co-authored examining the effectiveness, safety, and patient satisfaction of daylight-mediated methyl 5-aminolevulinate (MAL)–PDT. Dr Sapra also shares his clinical experience using this treatment and his approach to managing patient con...

Dr Kirk Barber speaks with Dr Jensen Yeung a dermatologist at the University of Toronto and the medical director of PERC, the Phototherapy Education and Research Centre at Women’s College Hospital in Toronto about the study he co-authored that examines the efficacy and safety of Apremilast monotherapy for moderate to severe Psoriasis. He also offers valuable insights into his use clinical use of a...

Dr. Neil Shear, Professor of Medicine ( Dermatology), and Pharmacology (clinical pharmacology and toxicology) at the University of Toronto and the current President of the Canadian Dermatology Association is one of the authors of the manuscript titled “Toxic Epidermal Necrolysis Spectrum Management At Sunnybrook Health Sciences Centre : Our Multidisciplinary Approach After Review Of The Current Ev...